ESC 365 - Cardiovascular outcomes & atherosclerosis: How do GLP-1 receptor antagonist provide benefits?

Open Access

Cardiovascular outcomes & atherosclerosis: How do GLP-1 receptor antagonist provide benefits?

Session: Expanding focus for cardiologists: The diabetic patient and cardiovascular outcomes

Topic: Diabetes and the Heart

Speaker: Doctor J. Plutzky (Boston, US)

Organised by PACE-CME, supported by Novo Nordisk A/S in the form of an educational grant

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Jorge Plutzky

Brigham and Women's Hospital, Boston (United States of America)

5 presentations

0 follower

4 more presentations in this session

Introduction.

Speaker: Professor U. Landmesser (Berlin, DE)

The cardiology challenge to manage diabetes in cardiovascular risk reduction.

Speaker: Professor N. Marx (Aachen, DE)

Changing paradigm in prediabetes and CVD: Potential for new concepts and new tools.

Speaker: Professor J. Deanfield (London, GB)

Discussion.

Speaker: Professor J. Deanfield (London, GB)

Access the full session

Expanding focus for cardiologists: The diabetic patient and cardiovascular outcomes

Speakers: Doctor J. Plutzky, Professor U. Landmesser, Professor N. Marx, Professor J. Deanfield, Professor J. Deanfield

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources